APA (7th ed.) Citation

Chai, J., Lv, J., Xiong, J., Chen, X., Luo, S., Luo, Z., . . . Luo, M. A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: A case report. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Chai, Jingjing, Jiaqi Lv, Jian Xiong, Xiuwen Chen, Senyuan Luo, Zhiguo Luo, Zhiguo Luo, and Ming Luo. A Remarkable and Durable Response to Tislelizumab Treatment of an Anaplastic Thyroid Carcinoma Without Targetable Genomic Alterations: A Case Report. Frontiers Media S.A.

MLA (9th ed.) Citation

Chai, Jingjing, et al. A Remarkable and Durable Response to Tislelizumab Treatment of an Anaplastic Thyroid Carcinoma Without Targetable Genomic Alterations: A Case Report. Frontiers Media S.A.